article

1. Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis..  RMD open.  12. 2026
2. Impact of Dual Rheumatoid Factor and Anticitrullinated Protein Antibody Seropositive, Single Seropositive, and Seronegative Rheumatoid Arthritis on Outcomes..  Arthritis care & research.  2026
3. Long-Term Outcomes in Seronegative Rheumatoid Arthritis..  Arthritis care & research.  2025
4. Differences in Cause-Specific Mortality in Patients With Rheumatoid Arthritis by Sex and Seropositivity..  The Journal of rheumatology.  52:1238-1244. 2025
5. Risk factors for incident atrial fibrillation in rheumatoid arthritis patients: A population based cohort study..  Seminars in arthritis and rheumatism.  -. 2025
6. Introducing a foundational sequence transformer for range adaptive nucleotide decoding (STRAND)..  Briefings in bioinformatics.  26. 2025
7. Integrative multi-omic profiling in blood reveals distinct immune and metabolic signatures between ACPA-negative and ACPA-positive rheumatoid arthritis..  Frontiers in immunology.  -. 2025
8. Exploring Factors Associated With Cognitive Impairment in Rheumatoid Arthritis..  Arthritis care & research.  2025
9. Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients With Rheumatoid Arthritis..  The Journal of rheumatology.  52:988-996. 2025
10. Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritis..  RMD open.  11. 2025
11. Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment design..  Contemporary clinical trials.  -. 2025
12. Carpal Tunnel Syndrome as an Early Underrecognized Feature of Rheumatoid Arthritis: A Population-Based Study of Carpal Tunnel Syndrome Occurrence Before and After Rheumatoid Arthritis Incidence..  Arthritis care & research.  77:1332-1339. 2025
13. New horizons in advancing lifestyle medicine for older adults utilizing a transdisciplinary approach: gaps and opportunities..  Age and ageing.  54. 2025
14. Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study..  Rheumatology international.  45:-. 2025
15. Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia..  Seminars in arthritis and rheumatism.  -. 2025
16. Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use..  RMD open.  11. 2025
17. Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study..  The Journal of rheumatology.  52:210-218. 2025
18. Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities..  The Lancet. Rheumatology.  6:e871-e880. 2024
19. Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist..  The Lancet. Rheumatology.  6:e892-e902. 2024
20. The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis..  Seminars in arthritis and rheumatism.  -. 2024
21. Validation of Different Dementia Code-Based Definitions in a Population-Based Study of Rheumatoid Arthritis..  The Journal of rheumatology.  51:978-984. 2024
22. Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan..  Rheumatology (Oxford, England).  63:1639-1648. 2024
23. Predicting treatment response to methotrexate: are we closer to solving the enigma?.  Rheumatology (Oxford, England).  63:1479-1480. 2024
24. Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis..  Annals of the rheumatic diseases.  83:556-563. 2024
25. Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis..  Current opinion in rheumatology.  36:203-208. 2024
26. Association between sinusitis and incident rheumatic diseases: a population-based study..  RMD open.  10. 2024
27. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis..  Seminars in arthritis and rheumatism.  -. 2024
28. Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort..  RMD open.  9. 2023
29. Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritis..  Rheumatology (Oxford, England).  62:SI296-SI303. 2023
30. Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis..  The American journal of cardiology.  20-27. 2023
31. Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis..  The Journal of rheumatology.  50:1279-1286. 2023
32. Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018..  Seminars in arthritis and rheumatism.  -. 2023
33. Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity..  Scientific reports.  13:-. 2023
34. Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions..  The Journal of rheumatology.  50:881-888. 2023
35. Dr. Kodishala et al reply..  The Journal of rheumatology.  50:-. 2022
36. Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis..  Arthritis care & research.  75:76-84. 2022
37. Association between work physical activity, dietary factors, and risk of rheumatoid arthritis..  Seminars in arthritis and rheumatism.  -. 2022
38. Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-Based Cohort of Patients With Rheumatoid Arthritis..  Arthritis care & research.  75:210-219. 2022
39. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries..  European heart journal. Cardiovascular pharmacotherapy.  8:539-548. 2022
40. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort..  Arthritis care & research.  74:2042-2049. 2022
41. Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study..  The Journal of rheumatology.  50:48-55. 2022
42. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data..  Arthritis research & therapy.  24:-. 2022
43. Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)..  Therapeutic advances in musculoskeletal disease.  -. 2022
44. Dr. Gunderson et al reply..  The Journal of rheumatology.  49:-. 2022
45. Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach..  Arthritis care & research.  74:879-888. 2022
46. Future challenges in rheumatology - is telemedicine the solution?.  Therapeutic advances in musculoskeletal disease.  -. 2022
47. To the editor: Response to Kao et al..  Seminars in arthritis and rheumatism.  -. 2022
48. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging..  Journal of Alzheimer's disease : JAD.  89:943-954. 2022
49. Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs).  Therapeutic advances in musculoskeletal disease.  14:1759720X2211059. 2022
50. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis. 2022
51. Future challenges in rheumatology – is telemedicine the solution?.  Therapeutic advances in musculoskeletal disease.  14:1759720X2210816. 2022
52. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.  Journal of Alzheimer's disease : JAD.  89:943-954. 2022
53. The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study..  Seminars in arthritis and rheumatism.  -. 2021
54. Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis-A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed..  ACR open rheumatology.  3:870-878. 2021
55. Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study..  Arthritis research & therapy.  23:-. 2021
56. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis..  Genome medicine.  13:-. 2021
57. Body mass index trend and variability in rheumatoid arthritis..  Clinical rheumatology.  41:349-355. 2021
58. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit..  RMD open.  7. 2021
59. Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study..  Seminars in arthritis and rheumatism.  51:853-857. 2021
60. Defeating the Hydra of Excess Cardiovascular Disease Risk in Rheumatoid Arthritis - How Close Are We to Completing the Task?.  The Journal of rheumatology.  48:629-632. 2021
61. Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study..  The Journal of rheumatology.  48:1379-1387. 2021
62. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study..  The Journal of rheumatology.  48:1648-1654. 2021
63. Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis..  Arthritis care & research.  73:180-187. 2021
64. Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study..  The Journal of rheumatology.  48:1641-1647. 2021
65. Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis..  The Journal of rheumatology.  48:1508-1511. 2021
66. Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease..  Journal of the American College of Cardiology.  76:2226-2234. 2020
67. Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort..  Rheumatology and therapy.  7:979-991. 2020
68. Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis..  Autoimmunity reviews.  19:-. 2020
69. Reply..  Arthritis & rheumatology (Hoboken, N.J.).  72:2164-2165. 2020
70. New era for outcomes and management of rheumatoid arthritis: Facing the individualized treatment challenge..  Joint bone spine.  88:-. 2020
71. et al.  Annals of the rheumatic diseases.  81:-. 2020
72. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis..  Seminars in arthritis and rheumatism.  50:1348-1356. 2020
73. Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis..  Arthritis & rheumatology (Hoboken, N.J.).  72:733-749. 2020
74. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014..  Annals of the rheumatic diseases.  79:440-444. 2020
75. Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis..  Mayo Clinic proceedings.  94:2488-2498. 2019
76. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity..  Mayo Clinic proceedings.  94:2241-2248. 2019
77. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire..  Seminars in arthritis and rheumatism.  50:261-265. 2019
78. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population..  Seminars in arthritis and rheumatism.  50:25-29. 2019
79. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial..  Clinical rheumatology.  38:3025-3032. 2019
80. Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population..  Mayo Clinic proceedings.  94:1035-1039. 2019
81. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study..  Rheumatology (Oxford, England).  56:2154-2161. 2017
82. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk..  Current opinion in rheumatology.  29:277-284. 2017
83. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?.  The Journal of rheumatology.  44:732-739. 2017
84. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk..  Current opinion in rheumatology.  29:277-284. 2017
85. Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014..  Clinical rheumatology.  35:2427-36. 2016
86. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease..  Annals of the rheumatic diseases.  75:560-5. 2015
87. Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study..  The Journal of rheumatology.  41:1638-44. 2014
88. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study..  Arthritis care & research.  65:1592-9. 2013
89. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study..  Arthritis and rheumatism.  65:1713-8. 2013
90. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study..  Arthritis care & research.  65:854-61. 2013
91. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study..  The Journal of rheumatology.  40:1082-8. 2013
92. Cardiovascular risk in psoriasis: a population-based analysis with assessment of the framingham risk score..  Scientifica.  -. 2013
93. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study..  The Journal of rheumatology.  39:1355-62. 2012
94. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota..  Gastroenterology research and practice.  -. 2011
95. The influence of rheumatoid arthritis disease characteristics on heart failure..  The Journal of rheumatology.  38:1601-6. 2011
96. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease..  Arthritis care & research.  63:729-34. 2011
97. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study..  The Journal of rheumatology.  38:983-9. 2011
98. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases..  Arthritis and rheumatism.  63:633-9. 2011
99. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease..  Annals of the rheumatic diseases.  70:482-7. 2011
100. Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis..  Arthritis care & research.  63:39-52. 2011
101. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease..  The Journal of rheumatology.  38:29-35. 2010
102. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality..  Current rheumatology reports.  12:379-85. 2010
103. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases..  Rheumatology (Oxford, England).  50:6-15. 2010
104. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007..  Arthritis and rheumatism.  62:1576-82. 2010
105. Increased prevalence of diastolic dysfunction in rheumatoid arthritis..  Annals of the rheumatic diseases.  69:1665-70. 2010
106. Cardiovascular disease in rheumatoid arthritis: a step forward..  Current opinion in rheumatology.  22:342-7. 2010
107. Cardiovascular disease in rheumatoid arthritis: a step forward..  Current opinion in rheumatology.  22:342-7. 2010
108. Total cholesterol and LDL levels decrease before rheumatoid arthritis..  Annals of the rheumatic diseases.  69:1310-4. 2009